Wednesday, October 26, 2016
Wednesday, October 26, 2016
Kenneth F. Trofatter, Jr., MD, PhDPregnancy and Childbirth

Welcome to Health Matters. As we make improvements to Healthline, Health Matters has been put on hold. You can still read all of our experts' great articles on Healthline, but there'll be no new ones posted while we work diligently to enhance the Health Matters section. Comments have also been temporarily disabled. Check back soon for the new and improved health expert area of Healthline.

Plasminogen Activator Inhibitor-1 (PAI-1): Role in Adverse Pregnancy Outcome? - 1 - Introduction

Kenneth F. Trofatter, Jr., MD, PhD
In a post at the end of September, we summarized a series of questions from a 26 year old, otherwise healthy, reader who had had recurrent early first trimester pregnancy losses. Her ‘work-up’ to date had been relatively unremarkable, however, she was found to be a carrier for the plasminogen activator inhibitor-1 (PAI-1) 4G/4G polymorphism and her queries revolved around the possible role of PAI-1 polymorphisms in recurrent pregnancy loss (RPL), options for ‘therapy’, and the utility and safety of such therapy. In the last comment from her cited in that earlier post, she notified us that she had actually conceived again, but unfortunately, a few days later, she again miscarried. Is her PAI-1 polymorphism contributing to her early losses? To be honest with you, I don’t know at this point. I can think of other possibilities that may be just as likely, but her questions are very good ones, and it was well worth my time to look into the literature on the issue and perhaps draw some conclusions that may help her or another reader who is in a similar situation...

First of all, what is PAI-1? The best way to explain PAI-1 is to describe what it does. The blood clotting system is made up of many different factors, some which cause a clot to form and others which cause the clot to breakdown, and these coexist in a very delicate balance. When the blood clotting pathways are activated, fibrinogen, a soluble plasma glycoprotein, is polymerized to form fibrin which is then cross-linked by the action of factor XIII to form the ‘clot’. Under normal circumstances, as soon as a clot forms, it begins to be broken down by other plasma factors. Specifically, a substance called tissue plasminogen activator (tPA) converts an inactive plasma protein, plasminogen, to the active substance, plasmin, which then plays a critical role in the breakdown of fibrin (fibrinolysis), thereby ‘dissolving’ the clot. (Interestingly, and perhaps germane to our discussion at some later point, plasmin also plays important roles in ovulation, cell migration, and epithelial cell differentiation).

PAI-1 fits into this balance as the primary inhibitor of tPA and other ‘plasminogen activators’ in the blood. To put its role in perspective, by inhibiting tPA, PAI-1 prevents the activation of plasminogen, thereby controlling the rate and extent of fibrin degradation (clot break down, or fibrinolysis) that occurs. Overactivity of PAI-1 will therefore lead to a tendency to form (or maintain) clots and an underactivity will result in an increased risk for bleeding. (With regard to other known functions of plasmin mentioned above, overactivity of PAI-1 might then also impair ovulation, cell migration, and epithelial cell differentiation).

Control of PAI-1 production is complex, but it is at least partly determined on a genetic basis. Certain polymorphisms of PAI-1, 4G/4G and 4G/5G, are associated with increased blood concentrations of PAI-1. Elevated PAI-1 levels have been correlated with risk for both arterial and venous thromboembolic conditions (e.g., deep venous thrombosis, pulmonary embolism, and stroke) and atherosclerotic disease (.eg., coronary and carotid artery disease), especially if other genetic (e.g., factor V Leiden; prothrombin G20210A; MTHFR polymorphisms; protein C, protein S, and antithrombin III deficiencies) or inherited (e.g., antiphospholipid antibodies; lupus anticoagulant; anti-beta-1-glycoprotein) thrombophilias are also present. Individuals with insulin resistance syndromes and diabetes mellitus frequently have elevated PAI-1 levels. Obesity and hyperlipidemia are also associated with elevated PAI-1 and under certain circumstances, weight reduction and/or reduction in cholesterol and triglycerides, can lead to reduction in PAI-1 levels.

In our next post on this subject, we will begin to explore the possible association and mechanisms of PAI-1 activity with adverse pregnancy outcome and recurrent pregnancy loss…

Labels: , ,

Permalink and Comments | Email Post


  • At Wed Dec 17, 04:59:00 PM 2008, Anonymous Anonymous said…

    I'm wondering if you can provide some feedback to me.

    I'm currently 9 weeks pregnant with my second child. My first pregnancy was fairly unremarkable, until at 8 months my blood pressure began to go up (the highest readings were 150/90 but most were lower) I was taken out of work and put on light bed rest. I had a doppler ultrasound at 36 weeks and the placenta appeared normal. I was induced at 39 weeks, but ended up having an emergency c-section when the baby had decels during contractions. When he was born he did not breathe and was in the NICU for 9 days with Hypoxic Ischaemic Encephalopathy. After follow-ups with neurologists and hematologists, it was found that he had two infarctions perinatally. My placenta pathology report showed no clots. Then my son was found to have PAI-1 (4G/5G). My husband and I were also tested - I have PAI-1 4G/4G. I have not yet been tested for any other blood disorders (like Factor 5 Leiden etc) but I have a script to go have this done, as well as having the PAI-1 levels tested.
    Is there any reason why I could not try to have a VBAC? Do I have to take any medications during my pregnancy? I would prefer not to take anything and would really like to try for a VBAC.
    What do you think?

  • At Wed May 20, 03:51:00 PM 2009, Anonymous Anonymous said…

    My doctor has recently found through blood testing that I have the PAI-1 4G/4G genetic mutation (?). He is unable to tell me what this means, other than to tell me that I am no longer allowed to take any borth control pills. I do understand the clotting factor, but is there ANY pill that I can take? I don't trust condoms, etc, and like the regularity the pill provides my body. Please help, no one seems to be able to tell me what to do....

  • At Mon Sep 07, 02:43:00 AM 2009, Anonymous Cholesterol Reduction Treatment said…

    Quite an informative post, indeed. Thanks for sharing.


<< Home

The Healthline Site, its content, such as text, graphics, images, search results, HealthMaps, Trust Marks, and other material contained on the Healthline Site ("Content"), its services, and any information or material posted on the Healthline Site by third parties are provided for informational purposes only. None of the foregoing is a substitute for professional medical advice, examination, diagnosis, or treatment. Always seek the advice of a physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Healthline Site. If you think you may have a medical emergency, call your doctor or 911 immediately. Please read the Terms of Service for more information regarding use of the Healthline Site.

Copyright © 2005 - 2016 Healthline Networks, Inc. All rights reserved.
Healthline is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations. more details